Of note, knockout of MARCH5 also sensitized A549 lung adenocarcinoma and U2OS osteosarcoma cells to ABT737 treatment, indicating that the observed sensitization was not limited to HeLa cells (Supplementary Fig 1b, 1c). The gene discussed is MARCHF5; the disease is osteosarcoma.